FDA Patient Safety News: Show - Duragesic - Document - PDFSEARCH.IO

First Page		Document Content
Pharmaceutical industry Food and Drug Administration Clinical research Duragesic Fentanyl Transdermal patch Adverse event Varenicline Botulinum toxin Medicine Pharmaceutical sciences Pharmacology		FDA Patient Safety News: Show #74, April 2008 Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 135,04 KB Share Document on Facebook

	HEROIN, FENTANYL & OTHER OPIOIDS A Comprehensive Resource for Families with a Teen or Young Adult DocID: 1vp68 - View Document
	Fentanyl Clandestine Lab Precursors Some precursors that may be observed associated to a clandestine drug lab producing Fentanyl are:  Anilin  1-Benzyl-4-piperidone DocID: 1vngC - View Document
	1 NAME ARK™ Fentanyl Calibrator 2 INTENDED USE ARK Fentanyl Calibrator is intended for use in calibration of the ARK Fentanyl Assay. DocID: 1vjTb - View Document
	1 NAME ARK™ Fentanyl Control 2 INTENDED USE This product is intended for Criminal Justice and Forensic Use Only. ARK Fentanyl Control is an assayed control material intended for use in quality control of the DocID: 1uGno - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SUBSYS safely and effectively. See full prescribing information for SUBSYS. SUBSYS®(fentanyl sublingual spray), CII DocID: 1uA0W - View Document